Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 188

Sort by

Sort Order Select

Journal Articles

Investigating 'No Shows' at a Hospital-Based Pediatric Sickle Cell Disease Clinic

Nicole Ivette Bohnker, MPH, Kay Linn Saving, MD

Blood (2019) 134 (Supplement_1): 1032.

https://doi.org/10.1182/blood-2019-121345

Published: 2019

Journal Articles

Advancing Healthcare Outcomes for Sickle Cell Disease in Nigeria Using Mobile Health Tools

Arwa Fraiwan, PhD, Muhammad Noman Hasan, MS, Ran An, PhD, Amy J. Rezac, Nicholas J. Kocmich, Tolulope Oginni, BS, Grace Mfon Olanipekun, Fatimah Hassan-Hanga, MD, Binta W. Jibir, MBBS MPH, Safiya Gambo, MBBS, Priyaleela Thota, MD, Stephen K. Obaro, MD PhD, Umut A. Gurkan, PhD

Blood (2019) 134 (Supplement_1): 2173.

https://doi.org/10.1182/blood-2019-131344

Published: 2019

Journal Articles

The Diagnostic Performance of a Non-Emergency Department-Based Deep Vein Thrombosis Ambulatory Care Pathway

Pape-Mamadou Sene, PharmD, Denis Yahiaoui, MD, Maral Koolian, MD FRCPC, Vicky Tagalakis, MD FRCPC

Blood (2019) 134 (Supplement_1): 3405.

https://doi.org/10.1182/blood-2019-124663

Published: 2019

Journal Articles

Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017

Shangari Vijenthira, Chantal Armali, Helen Downie, Ann Wilson, Kathy Paton, Brian Berry, Christine Cserti-Gazdewich, Jeannie Callum

Blood (2019) 134 (Supplement_1): 3689.

https://doi.org/10.1182/blood-2019-130615

Published: 2019

Journal Articles

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Raven Myrick, MSN, CRNP, Brandi Pernell, DNP, Avi Madan-Swain, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO, MSPH

Blood (2019) 134 (Supplement_1): 4691.

https://doi.org/10.1182/blood-2019-131059

Published: 2019

Journal Articles

Final Development of the First Generic Quality of Life and Symptoms Measure Specific for Hematological Malignancies: The HM-PRO

Pushpendra Goswami, PhD MSc, BPharm, Tatiana Ionova, DSc, Esther Natalie Oliva, PhD, Roger Else, Jonathan Kell, MD, Adele K. Fielding, MBBS,PhDFRCP,FRCPath, Daniel Jennings, Marina Karakantza, MD, Saad Al-Ismail, MD, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Stewart McConnell, Catherine Langton, Sam Salek, PhDRPh FFPM MCMS MRPSGB FESCP

Blood (2019) 134 (Supplement_1): 3484.

https://doi.org/10.1182/blood-2019-129030

Published: 2019

Journal Articles

Health Literacy, Self-Efficacy and Knowledge of Sickle Cell Disease Among Caregivers

Maite E. Houwing, MD, Rowena Grohssteiner, BSc, Sonja A.M.C. Teuben, Jan A Hazelzet, MD PhD, Anne P.J. de Pagter, MD PhD, Mirjam P. Fransen, Marjon H. Cnossen, MD PhD

Blood (2019) 134 (Supplement_1): 4841.

https://doi.org/10.1182/blood-2019-129888

Published: 2019

Journal Articles

Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

Xinran Ma, MSc, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, PhD, Jingjing Wu, Xudong Zhang, Xiaoyan Feng, Zhiyuan Zhou, Yu Chang, Zhaoming Li, MD PhD, Ken H. Young, Mingzhi Zhang

Blood (2019) 134 (Supplement_1): 2873.

https://doi.org/10.1182/blood-2019-127912

Published: 2019

Journal Articles

Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell Disease

Soumitri Sil, PhD, Kristina Lai, MPH, Jennifer L. Lee, PhD, Jordan Gilleland-Marchak, PhD ABPP, Beth Thompson, PhD, Lindsey L Cohen, PhD, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 418.

https://doi.org/10.1182/blood-2019-130580

Published: 2019

Journal Articles

Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies

Vinay B Rao, Emmanuelle Belanger, PhD, Pamela C Egan, MD, Thomas W. LeBlanc, MDMA,MHS, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 384.

https://doi.org/10.1182/blood-2019-121955

Published: 2019

Journal Articles

Oral Arsenic Trioxide in Front Line Therapy for Acute Promyelocytic Leukemia. A Prospective Costa Rican Study

Mariela Rodriguez, MD, Ronald Rojas, Alejandra Vargas, MD, Miguel Angel Rodriguez, MD, Claudia Garcia, MD, Juliana Esquivel, MD, Jose Gerardo Rojas, MD, Willem Bujan Boza, MD

Blood (2019) 134 (Supplement_1): 3838.

https://doi.org/10.1182/blood-2019-122627

Published: 2019

Journal Articles

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

John McKay, DO, Matthew Gayhart, MD, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Edward B. Perkins, MD PhD

Blood (2019) 134 (Supplement_1): 5140.

https://doi.org/10.1182/blood-2019-129429

Published: 2019

Journal Articles

Adult Case Series of Extramedullary Relapsing Acute Myeloid Leukemia (AML) after Allogeneic Stem Cell Transplantation in Whom a Rapid Response and a Reasonably Long Remission Could be Achieved with Gemtuzumab Ozogamycin (GO)

Omur Gokmen Sevindik, MD, Ali Ihsan Gemici, Furkan Selim Usta, Asli Çakır, Sevil Sadri, MD, Hüseyin Beköz, Fatma Deniz Sargın

Blood (2019) 134 (Supplement_1): 5129.

https://doi.org/10.1182/blood-2019-126195

Published: 2019

Journal Articles

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

My L Nguyen, PharmD, Catherine Burdalski, PharmD, BCOP, Syed Abbas Ali, MD, Lindsay Kohler, BS, PharmD Candidate, Steven Gilmore, PharmD, BCOP

Blood (2019) 134 (Supplement_1): 5811.

https://doi.org/10.1182/blood-2019-125391

Published: 2019

Journal Articles

Comparison of the Serum Metabolic Signatures Based on 1 H NMR between Thrombotic Antiphospholipid Syndrome (APS) Patients and Healthy Individuals

Melissa Quintero, PhD, Silmara Aparecida De Lima Montalvão, PhD, Ljubica Tasic, PhD, Stephany Cares Huber, PhD, Joyce Maria Annichino- Bizzacchi, MD PhD

Blood (2019) 134 (Supplement_1): 5769.

https://doi.org/10.1182/blood-2019-131927

Published: 2019

Journal Articles

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

Piyanuch Kongtim, MD, Kotchanut Litlueangdet, Darunee Emrat, MD BSc, Dhosaporn Charoenjit, MD, Supawee Saengboon, MD, Wasithep Limvorapitak, MD, Nonglak Kanitsap, MD, Hataiwan Ratanabunjerdkul, MD

Blood (2019) 134 (Supplement_1): 2421.

https://doi.org/10.1182/blood-2019-123682

Published: 2019

Journal Articles

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Tereza Popkova, MD, Katarina Hradska, MD, Jana Mihalyova, MD, Michaela Skorupova, Tomas Jelinek, MD, Juraj Duras, MD, Zdenek Koristek, MD PhD, Milan Navratil, MD, Katerina Benkova, MD, Hana Plonkova, MD, Jana Zuchnicka, MD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD

Blood (2019) 134 (Supplement_1): 4757.

https://doi.org/10.1182/blood-2019-127011

Published: 2019

Journal Articles

Erythrocyte Cytochrome b Reductase 1 Protein Levels and Structure in Sickle Cell Patients

Richard Kulmacz, PhD, Hamidreza Farzaneh, MS, Kathryn L McElhinney, BS, Jose M. Rodriguez, BS, Nicole C. Thomason, BS, Ehsan Irajizad, BE, Vladimir Berka, PhD, Wen Liu, PhD, Modupe Idowu, MD, Harinder S. Juneja, MD

Blood (2018) 132 (Supplement 1): 3654.

https://doi.org/10.1182/blood-2018-99-119885

Published: 2018

Journal Articles

One-Day Low-Dose Etoposide Is an Effective Chemomobilization Regimen with Minimal Toxicity for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Multicenter Study from Tertiary Hospitals in Korea

Yong Park, MD, Dae Sik Kim, MD PhD, Ka-Won Kang, MD, Byung-Hyun Lee, MD, Eun Sang Yu, MD, Min Ji Jeon, MD, Hojoon Choi, MD, Se Ryeon Lee, MD PhD, Hwa Jung Sung, MD PhD, Chul Won Choi, MD PhD, Kihyun Kim, MD PhD, Byung Soo Kim, MD PhD, Seok Jin Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3347.

https://doi.org/10.1182/blood-2018-99-115625

Published: 2018

Journal Articles

Plasma Thymus and Activation-Regulated Chemokine (TARC) As Diagnostic Marker in Pediatric Hodgkin Lymphoma

Eline Zijtregtop, MD PhDcandidate, Waichu Wong, BSc, Friederike Meyer- Wentrup, MD PhD, Martha Lopez-Yurda, PhD, Raoull Hoogendijk, MSc, Patty Kok, BSc, Michel Zwaan, Prof., MD PhD, Auke Beishuizen, MD PhD

Blood (2018) 132 (Supplement 1): 5312.

https://doi.org/10.1182/blood-2018-99-111861

Published: 2018

NARROW

Investigating 'No Shows' at a Hospital-Based Pediatric Sickle Cell Disease Clinic

Advancing Healthcare Outcomes for Sickle Cell Disease in Nigeria Using Mobile Health Tools

The Diagnostic Performance of a Non-Emergency Department-Based Deep Vein Thrombosis Ambulatory Care Pathway

Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Final Development of the First Generic Quality of Life and Symptoms Measure Specific for Hematological Malignancies: The HM-PRO

Health Literacy, Self-Efficacy and Knowledge of Sickle Cell Disease Among Caregivers

Efficacy and Safety of Apatinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: An Open-Label, Single-Arm, Prospective Study

Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell Disease

Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies

Oral Arsenic Trioxide in Front Line Therapy for Acute Promyelocytic Leukemia. A Prospective Costa Rican Study

Venetoclax and Cytarabine in AML Transformed from Myelofibrosis

Adult Case Series of Extramedullary Relapsing Acute Myeloid Leukemia (AML) after Allogeneic Stem Cell Transplantation in Whom a Rapid Response and a Reasonably Long Remission Could be Achieved with Gemtuzumab Ozogamycin (GO)

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

Comparison of the Serum Metabolic Signatures Based on 1 H NMR between Thrombotic Antiphospholipid Syndrome (APS) Patients and Healthy Individuals

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Erythrocyte Cytochrome b Reductase 1 Protein Levels and Structure in Sickle Cell Patients

One-Day Low-Dose Etoposide Is an Effective Chemomobilization Regimen with Minimal Toxicity for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: A Multicenter Study from Tertiary Hospitals in Korea

Plasma Thymus and Activation-Regulated Chemokine (TARC) As Diagnostic Marker in Pediatric Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only